Contact UsBiological Products
> Biopharmaceutical Industry Insight & News > Biological Products
| Product | Epokine | Company | CJ HealthCare corp |
|---|---|---|---|
| Classification | Recombinant DNA product | Active Ingredient | Recombinant human erythropoietin 1000, 2000, 3000, 4000, 10000 Units per prefilled-syringe or vial |
| Reference Product | Approval Date | 2010 | |
| Indication | ⓐ Treatment of anemia in chronic renal failure patients ⓑ Treatment of anemia in cancer patients on chemotherapy ⓒ For the patients participating in self blood preservation |
||
| Description |
Epokine? is the most reliable choice for renal anemia and was developed 1st in Korea and 3rd in the world.
Epokine? is safe and effective in treating anemia of hemodialysis patients with end-stage renal disease. |
||
Korea Biomedicine Industry Association(KoBIA)
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
COPYRIGHT BY KoBIA. ALL RIGHTS RESERVED.